相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。TGF-β sensitivity is determined by N-linked glycosylation of the type II TGF-β receptor
Young-Woong Kim et al.
BIOCHEMICAL JOURNAL (2012)
EGFR Signaling Promotes TGFβ-Dependent Renal Fibrosis
Jianchun Chen et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2012)
Glucosamine Modulates TNF-α-Induced ICAM-1 Expression and Function Through O-Linked and N-Linked Glycosylation in Human Retinal Pigment Epithelial Cells
Ching-Long Chen et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2012)
Cellular and molecular mechanisms of renal fibrosis
Youhua Liu
NATURE REVIEWS NEPHROLOGY (2011)
Glucosamine regulation of LPS-mediated inflammation in human bronchial epithelial cells
Yuh-Lin Wu et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2010)
Glucosamine Exerts a Neuroprotective Effect via Suppression of Inflammation in Rat Brain Ischemia/Reperfusion Injury
So-Young Hwang et al.
GLIA (2010)
Vitamin D Receptor Attenuates Renal Fibrosis by Suppressing the Renin-Angiotensin System
Yan Zhang et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2010)
An integrative view on the role of TGF-β in the progressive tubular deletion associated with chronic kidney disease
Omar Garcia-Sanchez et al.
KIDNEY INTERNATIONAL (2010)
Renal fibrosis: novel insights into mechanisms and therapeutic targets
Peter Boor et al.
NATURE REVIEWS NEPHROLOGY (2010)
10 mM glucosamine prevents activation of proADAMTS5 (aggrecanase-2) in transfected cells by interference with post-translational modification of furin
D. R. McCulloch et al.
OSTEOARTHRITIS AND CARTILAGE (2010)
New regulatory mechanisms of TGF-β receptor function
Jong Seok Kang et al.
TRENDS IN CELL BIOLOGY (2009)
Oral administration of GW788388, an inhibitor of TGF-β type I and II receptor kinases, decreases renal fibrosis
M. Petersen et al.
KIDNEY INTERNATIONAL (2008)
Glucosamine hydrochloride specifically inhibits COX-2 by preventing COX-2 N-glycosylation and by increasing COX-2 protein turnover in a proteasome-dependent manner
Byeong-Churl Jang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
IN-1130, a novel transforming growth factor-β type I receptor kinase (ALK5) inhibitor, suppresses renal fibrosis in obstructive nephropathy
J-A Moon et al.
KIDNEY INTERNATIONAL (2006)
N-glycosylation of fibroblast growth factor receptor 1 regulates ligand and heparan sulfate co-receptor binding
Laurence Duchesne et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Mechanisms of glucosamine-induced suppression of the hepatic assembly and secretion of apolipoprotein B-100-containing lipoproteins
Wei Qiu et al.
JOURNAL OF LIPID RESEARCH (2006)
Epithelial to mesenchymal transition in renal fibrogenesis: Pathologic significance, molecular mechanism, and therapeutic intervention
YH Liu
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2004)
Divergent effects of low versus high dose anti-TGF-beta antibody in puromycin aminonucleoside nephropathy in rats
LJ Ma et al.
KIDNEY INTERNATIONAL (2004)
The role of N-glycosylation in function and surface trafficking of the human dopamine transporter
LB Li et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Mechanisms of TGF-β signaling from cell membrane to the nucleus
YG Shi et al.
CELL (2003)
TGF-β signaling in renal disease
EP Böttinger et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2002)
Role of connective tissue growth factor in fibronectin expression and tubulointerstitial fibrosis
H Yokoi et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2002)
Long-term effects of glucosamine sulphate on osteoarthritis progression: a randomised, placebo-controlled clinical trial
JY Reginster et al.
LANCET (2001)
TGFβ signaling in growth control, cancer, and heritable disorders
J Massagué et al.
CELL (2000)